__NUXT_JSONP__("/drugs/SERD_ZB-716", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1853279-29-4",chebiId:b,chemicalFormula:b,definition:"An orally bioavailable selective estrogen receptor degrader\u002Fdownregulator (SERD) and a structural analog of fulvestrant, with potential antineoplastic activity. Upon oral administration, SERD ZB-716 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.",fdaUniiCode:"E35ZN95LMT",identifier:"C179265",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C2116"],synonyms:["Borestrant",c,"Selective Estrogen Receptor Alpha Degrader ZB716","Selective Estrogen Receptor Degrader ZB716","ZB 716","ZB-716","ZB716"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FSERD_ZB-716",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("SERD_ZB-716","","SERD ZB-716","2021-10-30T13:36:35.933Z")));